{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:10:03Z","timestamp":1779297003289,"version":"3.51.4"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T00:00:00Z","timestamp":1201651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T00:00:00Z","timestamp":1201651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s12016-007-8048-8","type":"journal-article","created":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T18:40:24Z","timestamp":1201632024000},"page":"283-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Infections and Autoimmunity: A Panorama"],"prefix":"10.1007","volume":"34","author":[{"given":"V.","family":"Pordeus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Szyper-Kravitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. M.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,30]]},"reference":[{"key":"8048_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1017\/S0269889705000384","volume":"18","author":"V Nutton","year":"2005","unstructured":"Nutton V (2005) The fatal embrace: Galen and the history of ancient medicine. Sci Context 18:111\u2013121","journal-title":"Sci Context"},{"key":"8048_CR2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1096\/fj.04-3541rev","volume":"19","author":"S De Flora","year":"2005","unstructured":"De Flora S, Quaglia A, Bennicelli C, Vercelli M (2005) The epidemiological revolution of the 20th century. FASEB J 19:892\u2013897","journal-title":"FASEB J"},{"key":"8048_CR3","volume-title":"Infection and autoimmunity","author":"Y Shoenfeld","year":"2004","unstructured":"Shoenfeld Y, Rose NR (2004) Infection and autoimmunity, 1st edn. Elsevier, Amsterdam","edition":"1"},{"key":"8048_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2796.2005.01490.x","volume":"257","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Jara LJ, Medina F et al (2005) Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. J Intern Med 257:549\u2013557","journal-title":"J Intern Med"},{"key":"8048_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1365-2249.2004.02704.x","volume":"139","author":"M Yamazaki","year":"2005","unstructured":"Yamazaki M, Kitamura R, Kusano S et al (2005) Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein\u2013Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjogren\u2019s syndrome patients with pulmonary involvements. Clin Exp Immunol 139:558\u2013568","journal-title":"Clin Exp Immunol"},{"key":"8048_CR6","volume-title":"Infection and autoimmunity","author":"MP Pender","year":"2004","unstructured":"Pender MP (2004) Epstein\u2013Barr virus and autoimmunity. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. 1st edn. Elsevier, Amsterdam","edition":"1"},{"key":"8048_CR7","volume-title":"Infection and autoimmunity","author":"MC Severin","year":"2004","unstructured":"Severin MC, Shoenfeld Y (2004) Parvovirus B19 infection and its association with autoimmune disease. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. 1st edn. Elsevier, Amsterdam","edition":"1"},{"key":"8048_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jcv.2004.11.011","volume":"33","author":"A Lundqvist","year":"2005","unstructured":"Lundqvist A, Isa A, Tolfvenstam T, Kvist G, Broliden K (2005) High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients. J Clin Virol 33:71\u201374","journal-title":"J Clin Virol"},{"key":"8048_CR9","first-page":"1825","volume":"22","author":"H Subair","year":"1995","unstructured":"Subair H, Tiwana H, Fielder M et al (1995) Elevation in anti-proteus antibodies in patients with rheumatoid arthritis from Bermuda and England. J Rheumatol 22:1825\u20131828","journal-title":"J Rheumatol"},{"key":"8048_CR10","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/rheumatology\/kei036","volume":"44","author":"MM Newkirk","year":"2005","unstructured":"Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR Jr, El-Gabalawy HS (2005) Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology (Oxford, England) 44:1433\u20131441","journal-title":"Rheumatology (Oxford, England)"},{"key":"8048_CR11","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1084\/jem.20041758","volume":"201","author":"H Yoshitomi","year":"2005","unstructured":"Yoshitomi H, Sakaguchi N, Kobayashi K, Brown GD, Tagami T, Sakihama T, Hirota K, Tanaka S, Nomura T, Miki I, Gordon S, Akira S, Nakamura T, Sakaguchi S (2005) A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. JEM 201:949\u2013960","journal-title":"JEM"},{"key":"8048_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1365-2567.2006.02361.x","volume":"118","author":"H Kai","year":"2006","unstructured":"Kai H, Shibuya K, Wang Y, Kameta H, Kameyama T, Tahara-Hanaoka S, Miyamoto A, Honda S, Matsumoto I, Koyama A, Sumida T, Shibuya A (2006) Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL\/6 mice. Immunology 118:233\u2013239","journal-title":"Immunology"},{"key":"8048_CR13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00109-006-0039-3","volume":"84","author":"MP Quinones","year":"2006","unstructured":"Quinones MP, Jimenez F, Martinez H et al (2006) CC chemokine receptor (CCR)-2 prevents arthritis development following infection by Mycobacterium avium. J Mol Med (Berlin, Germany) 84:503\u2013512","journal-title":"J Mol Med (Berlin, Germany)"},{"key":"8048_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1128\/IAI.74.1.248-256.2006","volume":"74","author":"S Yamanishi","year":"2006","unstructured":"Yamanishi S, Iizumi T, Watanabe E et al (2006) Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 74:248\u2013256","journal-title":"Infect Immun"},{"key":"8048_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/17402520600876895","volume":"13","author":"F Rocha","year":"2006","unstructured":"Rocha F (2006) Protective role of helminthiasis in the development of autoimmune diseases. Clin Dev Immunol 13:159\u2013162","journal-title":"Clin Dev Immunol"},{"key":"8048_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0024-3205(98)00315-4","volume":"63","author":"I Kato","year":"1998","unstructured":"Kato I, Endo-Tanaka K, Yokokura T (1998) Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA\/1 mice. Life Sci 63:635\u2013644","journal-title":"Life Sci"},{"key":"8048_CR17","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.169.4.2189","volume":"169","author":"M Costalonga","year":"2002","unstructured":"Costalonga M, Hodges JS, Herzberg MC (2002) Streptococcus sanguis modulates type II collagen-induced arthritis in DBA\/1J mice. J Immunol 169:2189\u20132195","journal-title":"J Immunol"},{"key":"8048_CR18","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1016\/j.vaccine.2005.03.005","volume":"23","author":"A Schattner","year":"2005","unstructured":"Schattner A (2005) Cosequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23:3876\u20133886","journal-title":"Vaccine"},{"key":"8048_CR19","first-page":"430","volume":"6","author":"M Tishler","year":"2004","unstructured":"Tishler M, Shoenfeld Y (2004) Vaccination may be associated with autoimmune diseases. IMAJ 6:430\u2013432","journal-title":"IMAJ"},{"key":"8048_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00296-005-0059-2","volume":"26","author":"E Tinazzi","year":"2006","unstructured":"Tinazzi E, Ficarra V, Simeoni S, Artibani W, Lunardi C (2006) Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review. Rheumatol Int 26:481\u2013488","journal-title":"Rheumatol Int"},{"key":"8048_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1081-1206(10)61379-8","volume":"97","author":"M Vasudev","year":"2006","unstructured":"Vasudev M, Zacharisen MC (2006) New onset rheumatoid arthritis after anthrax vaccination. Ann Allergy Asthma Immun 97:110\u2013112","journal-title":"Ann Allergy Asthma Immun"},{"key":"8048_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/jaut.1999.0346","volume":"14","author":"Y Shoenfeld","year":"2000","unstructured":"Shoenfeld Y, Aron-Maor A (2000) Vaccination and autoimmunity\u2014\u2018vaccinosis\u2019: a dangerous liaison? J Autoimmun 14:1\u201310","journal-title":"J Autoimmun"},{"key":"8048_CR23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","volume":"63","author":"GN DeLorenze","year":"2006","unstructured":"DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A (2006) Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 63:839\u2013844","journal-title":"Arch Neurol"},{"key":"8048_CR24","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","volume":"293","author":"LI Levin","year":"2005","unstructured":"Levin LI, Munger KL, Rubertone MV et al (2005) Temporal relationship between elevation of Epstein\u2013Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. J Am Med Assoc 293:2496\u20132500","journal-title":"J Am Med Assoc"},{"key":"8048_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/rmv.503","volume":"16","author":"S Haahr","year":"2006","unstructured":"Haahr S, Hollsberg P (2006) Multiple sclerosis is linked to Epstein\u2013Barr virus infection. Rev Med Virol 16:297\u2013310","journal-title":"Rev Med Virol"},{"key":"8048_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1191\/1352458506ms1291oa","volume":"12","author":"PG Bagos","year":"2006","unstructured":"Bagos PG, Nikolopoulos G, Ioannidis A (2006) Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler (Houndmills, Basingstoke, England) 12:397\u2013411","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"key":"8048_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1054\/mehy.2001.1276","volume":"57","author":"H Kissler","year":"2001","unstructured":"Kissler H (2001) Is multiple sclerosis caused by a silent infection with malarial parasites? A historico-epidemiological approach: part I. Med Hypotheses 57:280\u2013291","journal-title":"Med Hypotheses"},{"key":"8048_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cellimm.2006.03.003","volume":"239","author":"N Rubio","year":"2006","unstructured":"Rubio N, Sanz-Rodriguez F, Lipton HL (2006) Theiler\u2019s virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains. Cell Immunol 239:31\u201340","journal-title":"Cell Immunol"},{"key":"8048_CR29","doi-asserted-by":"publisher","first-page":"8581","DOI":"10.1128\/JVI.79.13.8581-8590.2005","volume":"79","author":"JL Croxford","year":"2005","unstructured":"Croxford JL, Olson JK, Anger HA, Miller SD (2005) Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis. J Virol 79:8581\u20138590","journal-title":"J Virol"},{"key":"8048_CR30","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1172\/JCI27372","volume":"116","author":"D Merkler","year":"2006","unstructured":"Merkler D, Horvath E, Bruck W, Zinkernagel RM, Del la Torre JC, Pinschewer DD (2006) \u201cViral deja vu\u201d elicits organ-specific immune disease independent of reactivity to self. J Clin Invest 116:1254\u20131263","journal-title":"J Clin Invest"},{"key":"8048_CR31","first-page":"67","volume":"206","author":"MB Oldstone","year":"1996","unstructured":"Oldstone MB, von Herrath M, Evans CF, Horwitz MS (1996) Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. Curr Top Microbiol Immunol 206:67\u201383","journal-title":"Curr Top Microbiol Immunol"},{"key":"8048_CR32","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1128\/JCM.02532-05","volume":"44","author":"FC Westall","year":"2006","unstructured":"Westall FC (2006) Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol 44:2099\u20132104","journal-title":"J Clin Microbiol"},{"key":"8048_CR33","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/eji.200535785","volume":"36","author":"M Mohindru","year":"2006","unstructured":"Mohindru M, Kang B, Kim BS (2006) Initial capsid-specific CD4(+) T cell responses protect against Theiler\u2019s murine encephalomyelitisvirus-induced demyelinating disease. Eur J Immunol 36:2106\u20132115","journal-title":"Eur J Immunol"},{"key":"8048_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08916930500484799","volume":"39","author":"L McCoy","year":"2006","unstructured":"McCoy L, Tsunoda I, Fujinami RS (2006) Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 39:9\u201319","journal-title":"Autoimmunity"},{"key":"8048_CR35","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.4049\/jimmunol.175.10.6733","volume":"175","author":"S Jun","year":"2005","unstructured":"Jun S, Gilmore W, Callis G, Rynda A, Haddad A, Pascual DW (2005) A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine. J Immunol 175:6733\u20136740","journal-title":"J Immunol"},{"key":"8048_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/CDLI.10.4.564-572.2003","volume":"10","author":"DL Sewell","year":"2003","unstructured":"Sewell DL, Reinke EK, Co DO et al (2003) Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis. Clin Diagn Lab Immunol 10:564\u2013572","journal-title":"Clin Diagn Lab Immunol"},{"key":"8048_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1464-5491.2004.01182.x","volume":"21","author":"J Green","year":"2004","unstructured":"Green J, Casabonne D, Newton R (2004) Coxsackie B virus serology and type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med 21:507\u2013514","journal-title":"Diabet Med"},{"key":"8048_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cellimm.2005.04.009","volume":"233","author":"C Filippi","year":"2005","unstructured":"Filippi C, von Herrath M (2005) How viral infections affect the autoimmune process leading to type 1 diabetes. Cell Immunol 233:125\u2013132","journal-title":"Cell Immunol"},{"key":"8048_CR39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-044451271-0.50020-X","volume-title":"Infection and autoimmunity","author":"HS Jun","year":"2004","unstructured":"Jun HS, Yoon JW (2004) Viral Infections and type1 diabetes. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. 1st edn. Elsevier, Amsterdam, pp 229\u2013249","edition":"1"},{"key":"8048_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1023\/A:1024256305963","volume":"18","author":"E Altobelli","year":"2003","unstructured":"Altobelli E, Petrocelli R, Verrotti A, Valenti M (2003) Infections and risk of type I diabetes in childhood: a population-based case-control study. Eur J Epidemiol 18:425\u2013430","journal-title":"Eur J Epidemiol"},{"key":"8048_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0092-8674(04)00335-6","volume":"117","author":"C King","year":"2004","unstructured":"King C, Ilic A, Koelsch K, Sarvetnick N (2004) Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:265\u2013277","journal-title":"Cell"},{"key":"8048_CR42","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm1114","volume":"10","author":"MA Gronski","year":"2004","unstructured":"Gronski MA, Boulter JM, Moskophidis D et al (2004) TCR affinity and negative regulation limit autoimmunity. Nat Med 10:1234\u20131239","journal-title":"Nat Med"},{"key":"8048_CR43","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1128\/JVI.79.2.1045-1052.2005","volume":"79","author":"DV Serreze","year":"2005","unstructured":"Serreze DV, Wasserfall C, Ottendorfer EW et al (2005) Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 79:1045\u20131052","journal-title":"J Virol"},{"key":"8048_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2337\/diabetes.55.01.06.db05-0189","volume":"55","author":"MA Alyanakian","year":"2006","unstructured":"Alyanakian MA, Grela F, Aumeunier A et al (2006) Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes 55:179\u2013185","journal-title":"Diabetes"},{"key":"8048_CR45","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.4049\/jimmunol.177.4.2224","volume":"177","author":"T Raine","year":"2006","unstructured":"Raine T, Zaccone P, Mastroeni P, Cooke A (2006) Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J Immunol 177:2224\u20132233","journal-title":"J Immunol"},{"key":"8048_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1128\/IAI.00664-06","volume":"75","author":"KA Saunders","year":"2006","unstructured":"Saunders KA, Raine T, Cooke A, Lawrence CE (2006) Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun 75:397\u2013407","journal-title":"Infect Immun"},{"key":"8048_CR47","first-page":"45","volume":"64","author":"JB Harley","year":"2006","unstructured":"Harley JB, James JA (2006) Epstein\u2013Barr virus infection induces lupus autoimmunity. Bull Hosp Joint Dis 64:45\u201350","journal-title":"Bull Hosp Joint Dis"},{"key":"8048_CR48","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1177\/0961203306070009","volume":"15","author":"JB Harley","year":"2006","unstructured":"Harley JB, Harley IT, Guthridge JM, James JA (2006) The curiously suspicious: a role for Epstein\u2013Barr virus in lupus. Lupus 15:768\u2013777","journal-title":"Lupus"},{"key":"8048_CR49","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D","volume":"44","author":"JA James","year":"2001","unstructured":"James JA, Neas BR, Moser KL et al (2001) Systemic lupus erythematosus in adults is associated with previous Epstein\u2013Barr virus exposure. Arthritis Rheum 44:1122\u20131136","journal-title":"Arthritis Rheum"},{"key":"8048_CR50","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/art.20997","volume":"52","author":"CG Parks","year":"2005","unstructured":"Parks CG, Cooper GS, Hudson LL et al (2005) Association of Epstein\u2013Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 52:1148\u20131159","journal-title":"Arthritis Rheum"},{"key":"8048_CR51","first-page":"44","volume":"32","author":"CJ Chen","year":"2005","unstructured":"Chen CJ, Lin KH, Lin SC et al (2005) High prevalence of immunoglobulin A antibody against Epstein\u2013Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol 32:44\u201347","journal-title":"J Rheumatol"},{"key":"8048_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08916930310001624656","volume":"37","author":"CI Mockridge","year":"2004","unstructured":"Mockridge CI, Rahman A, Buchan S et al (2004) Common patterns of B cell perturbation and expanded V4\u201334 immunoglobulin gene usage in autoimmunity and infection. Autoimmunity 37:9\u201315","journal-title":"Autoimmunity"},{"key":"8048_CR53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/ard.59.1.64","volume":"59","author":"A Bengtsson","year":"2000","unstructured":"Bengtsson A, Widell A, Elmstahl S, Sturfelt G (2000) No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19. Ann Rheum Dis 59:64\u201366","journal-title":"Ann Rheum Dis"},{"key":"8048_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1386-6532(99)00038-4","volume":"14","author":"A Hemauer","year":"1999","unstructured":"Hemauer A, Beckenlehner K, Wolf H, Lang B, Modrow S (1999) Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient. J Clin Virol 14:73\u201377","journal-title":"J Clin Virol"},{"key":"8048_CR55","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000068885","volume":"206","author":"M Seishima","year":"2003","unstructured":"Seishima M, Oyama Z, Yamamura M (2003) Two-year follow-up study after human parvovirus B19 infection. Dermatology 206:192\u2013196","journal-title":"Dermatology"},{"key":"8048_CR56","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/08916930500285667","volume":"38","author":"A Hrycek","year":"2005","unstructured":"Hrycek A, Kusmierz D, Mazurek U, Wilczok T (2005) Human cytomegalovirus in patients with systemic lupus erythematosus. Autoimmunity 38:487\u2013491","journal-title":"Autoimmunity"},{"key":"8048_CR57","first-page":"27932","volume":"177","author":"H Wang","year":"2006","unstructured":"Wang H, Nicholas MW, Conway KL et al (2006) EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol 177:27932\u2013802","journal-title":"J Immunol"},{"key":"8048_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2249.2005.02974.x","volume":"143","author":"M Chang","year":"2006","unstructured":"Chang M, Pan MR, Chen DY, Lan JL (2006) Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB\/W F1 mice. Clin Exp Immunol 143:167\u2013179","journal-title":"Clin Exp Immunol"},{"key":"8048_CR59","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/BF01541229","volume":"16","author":"BB Mittleman","year":"1996","unstructured":"Mittleman BB, Morse HC 3rd, Payne SM, Shearer GM, Mozes E (1996) Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection. J Clin Immunol 16:230\u2013236","journal-title":"J Clin Immunol"},{"key":"8048_CR60","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.biopha.2004.04.009","volume":"58","author":"Y Kuroda","year":"2004","unstructured":"Kuroda Y, Nacionales DC, Akaogi J, Reeves WH, Satoh M (2004) Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother 58:325\u2013337","journal-title":"Biomed Pharmacother"},{"key":"8048_CR61","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.4049\/jimmunol.157.7.3200","volume":"157","author":"M Satoh","year":"1996","unstructured":"Satoh M, Hamilton KJ, Ajmani AK et al (1996) Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol 157:3200\u20133206","journal-title":"J Immunol"},{"key":"8048_CR62","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(88)90741-6","volume":"2","author":"P Saikku","year":"1988","unstructured":"Saikku P, Leinonen M, Mattila K et al (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2:983\u2013986","journal-title":"Lancet"},{"key":"8048_CR63","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0195-668X(02)00801-1","volume":"24","author":"J Danesh","year":"2003","unstructured":"Danesh J, Whincup P, Walker M (2003) Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. Eur Heart J 24:881","journal-title":"Eur Heart J"},{"key":"8048_CR64","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1046\/j.1469-0691.2002.00407.x","volume":"8","author":"M Degre","year":"2002","unstructured":"Degre M (2002) Has cytomegalovirus infection any role in the development of atherosclerosis? Clin Microbiol Infect 8:191\u2013195","journal-title":"Clin Microbiol Infect"},{"key":"8048_CR65","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2005.03.017","volume":"183","author":"JD Beck","year":"2005","unstructured":"Beck JD, Eke P, Lin D et al (2005) Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults. Atherosclerosis 183:342\u2013348","journal-title":"Atherosclerosis"},{"key":"8048_CR66","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/B978-044451271-0\/50055-7","volume-title":"Infections and autoimmunity","author":"J Frosteg\u00e5rd","year":"2004","unstructured":"Frosteg\u00e5rd J (2004) Infection and atherosclerosis. In: Shoenfeld Y, Rose NR (eds) Infections and autoimmunity. Elsevier, Amsterdam, pp 701\u2013709"},{"key":"8048_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.it.2004.10.009","volume":"26","author":"C Lunardi","year":"2005","unstructured":"Lunardi C, Bason C, Corrocher R, Puccetti A (2005) Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol 26:19\u201324","journal-title":"Trends Immunol"},{"key":"8048_CR68","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2004.12.035","volume":"181","author":"I Vliegen","year":"2005","unstructured":"Vliegen I, Herngreen SB, Grauls GE, Bruggeman CA, Stassen FR (2005) Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice. Atherosclerosis 181:39\u201344","journal-title":"Atherosclerosis"},{"key":"8048_CR69","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1161\/01.ATV.0000082462.26258.FE","volume":"23","author":"E Lalla","year":"2003","unstructured":"Lalla E, Lamster IB, Hofmann MA et al (2003) Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 23:1405\u20131411","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"8048_CR70","doi-asserted-by":"crossref","first-page":"2834283","DOI":"10.1161\/01.CIR.103.23.2834","volume":"103","author":"G Caligiuri","year":"2001","unstructured":"Caligiuri G, Rottenberg M, Nicoletti A, Wigzell H, Hansson GK (2001) Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 103:2834283\u20132834288","journal-title":"Circulation"},{"key":"8048_CR71","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nm876","volume":"9","author":"CJ Binder","year":"2003","unstructured":"Binder CJ, Horkko S, Dewan A et al (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9:736\u2013743","journal-title":"Nat Med"},{"key":"8048_CR72","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2003.014175","volume":"63","author":"R Cervera","year":"2004","unstructured":"Cervera R, Asherson RA, Acevedo ML et al (2004) Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 63:1312\u20131317","journal-title":"Ann Rheum Dis"},{"key":"8048_CR73","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1191\/096120399678841034","volume":"8","author":"I Uthman","year":"1999","unstructured":"Uthman I, Tabbarah Z, Gharavi AE (1999) Hughes syndrome associated with cytomegalovirus infection. Lupus 8:775\u2013777","journal-title":"Lupus"},{"key":"8048_CR74","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcv.2004.07.013","volume":"32","author":"S van Hal","year":"2005","unstructured":"van Hal S, Senanayake S, Hardiman R (2005) Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein\u2013Barr virus infection. J Clin Virol 32:245\u2013247","journal-title":"J Clin Virol"},{"key":"8048_CR75","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1191\/096120399678847731","volume":"8","author":"Z Faghiri","year":"1999","unstructured":"Faghiri Z, Wilson WA, Taheri F, Barton EN, Morgan OS, Gharavi AE (1999) Antibodies to cardiolipin and beta2-glycoprotein-1 in HTLV-1-associated myelopathy\/tropical spastic paraparesis. Lupus 8:210\u2013214","journal-title":"Lupus"},{"key":"8048_CR76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1023\/B:JOCI.0000018058.28764.ce","volume":"24","author":"M Blank","year":"2004","unstructured":"Blank M, Asherson RA, Cervera R, Shoenfeld Y (2004) Antiphospholipid syndrome infectious origin. J Clin Immunol 24:12\u201323","journal-title":"J Clin Immunol"},{"key":"8048_CR77","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/rheumatology\/kel118","volume":"45","author":"M Blank","year":"2006","unstructured":"Blank M, Krause I, Magrini L et al (2006) Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford, England) 45:833\u2013841","journal-title":"Rheumatology (Oxford, England)"},{"issue":"Suppl 1","key":"8048_CR78","first-page":"88","volume":"62","author":"R Cervera","year":"2003","unstructured":"Cervera R, Gomez-Puerta JA, Espinosa G, Cucho M, Font J (2003) \u201cCAPS registry\u201d. A review of 200 cases from the International Registry of patients with the Catastrophic Antiphospholipid Syndrome (CAPS). Ann Rheum Dis 62(Suppl 1):88","journal-title":"Ann Rheum Dis"},{"key":"8048_CR79","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/art.22018","volume":"54","author":"S Bucciarelli","year":"2006","unstructured":"Bucciarelli S, Espinosa G, Cervera R et al (2006) Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 54:2568\u20132576","journal-title":"Arthritis Rheum"},{"key":"8048_CR80","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/096120339900800607","volume":"8","author":"EE Gharavi","year":"1999","unstructured":"Gharavi EE, Chaimovich H, Cucurull E et al (1999) Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. Lupus 8:449\u2013455","journal-title":"Lupus"},{"key":"8048_CR81","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/08916930600622348","volume":"39","author":"S Zampieri","year":"2006","unstructured":"Zampieri S, Ghirardello A, Iaccarino L et al (2006) Polymyositis\u2013dermatomyositis and infections. Autoimmunity 39:191\u2013196","journal-title":"Autoimmunity"},{"key":"8048_CR82","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00300245","volume":"14","author":"M Nishikai","year":"1994","unstructured":"Nishikai M (1994) Coxsackievirus infection and the development of polymyositis\/dermatomyositis. Rheumatol Int 14:43\u201346","journal-title":"Rheumatol Int"},{"key":"8048_CR83","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1001\/jama.294.17.2170","volume":"294","author":"G Mamyrova","year":"2005","unstructured":"Mamyrova G, Rider LG, Haagenson L, Wong S, Brown KE (2005) Parvovirus B19 and onset of juvenile dermatomyositis. J Am Med Assoc 294:2170\u20132171","journal-title":"J Am Med Assoc"},{"key":"8048_CR84","doi-asserted-by":"publisher","first-page":"11849","DOI":"10.1128\/JVI.77.21.11849-11854.2003","volume":"77","author":"PE Tam","year":"2003","unstructured":"Tam PE, Weber-Sanders ML, Messner RP (2003) Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy. J Virol 77:11849\u201311854","journal-title":"J Virol"},{"key":"8048_CR85","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1128\/JVI.80.2.737-749.2006","volume":"80","author":"TE Morrison","year":"2006","unstructured":"Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT (2006) Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 80:737\u2013749","journal-title":"J Virol"},{"key":"8048_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0037-86822006000100001","volume":"39","author":"SG Andrade","year":"2006","unstructured":"Andrade SG, Campos RF, Sobral KS, Magalhaes JB, Guedes RS, Guerreiro ML (2006) Reinfections with strains of Trypanosoma cruzi, of different biodemes as a factor of aggravation of myocarditis and myositis in mice. Rev Soc Bras Med Trop 39:1\u20138","journal-title":"Rev Soc Bras Med Trop"},{"key":"8048_CR87","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/j.1365-2133.2005.06567.x","volume":"152","author":"T Ohtsuka","year":"2005","unstructured":"Ohtsuka T, Yamazaki S (2005) Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue. Br J Dermatol 152:1078\u20131080","journal-title":"Br J Dermatol"},{"key":"8048_CR88","first-page":"176","volume":"24","author":"AM Namboodiri","year":"2006","unstructured":"Namboodiri AM, Rocca KM, Kuwana M, Pandey JP (2006) Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis. Clin Exp Rheumatol 24:176\u2013178","journal-title":"Clin Exp Rheumatol"},{"key":"8048_CR89","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1046\/j.1523-5378.2002.00092.x","volume":"7","author":"L Kalabay","year":"2002","unstructured":"Kalabay L, Fekete B, Czirjak L et al (2002) Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 7:250\u2013256","journal-title":"Helicobacter"},{"key":"8048_CR90","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/80533","volume":"6","author":"C Lunardi","year":"2000","unstructured":"Lunardi C, Bason C, Navone R et al (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6:1183\u20131186","journal-title":"Nat Med"},{"key":"8048_CR91","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1365-2249.2004.02535.x","volume":"137","author":"I Gavanescu","year":"2004","unstructured":"Gavanescu I, Pihan G, Halilovic E, Szomolanyi-Tsuda E, Welsh RM, Doxsey S (2004) Mycoplasma infection induces a scleroderma-like centrosome autoantibody response in mice. Clin Exp Immunol 137:288\u2013297","journal-title":"Clin Exp Immunol"},{"key":"8048_CR92","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/01.bor.0000197999.58073.2e","volume":"18","author":"A Rodriguez-Pla","year":"2006","unstructured":"Rodriguez-Pla A, Stone JH (2006) Vasculitis and systemic infections. Curr Opin Rheumatol 18:39\u201347","journal-title":"Curr Opin Rheumatol"},{"key":"8048_CR93","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/rheumatology\/keg206","volume":"42","author":"A Eden","year":"2003","unstructured":"Eden A, Mahr A, Servant A et al (2003) Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study. Rheumatology (Oxford) 42:660\u2013664","journal-title":"Rheumatology (Oxford)"},{"key":"8048_CR94","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/rheumatology\/41.4.445","volume":"41","author":"J Helweg-Larsen","year":"2002","unstructured":"Helweg-Larsen J, Tarp B, Obel N, Baslund B (2002) No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford) 41:445\u2013449","journal-title":"Rheumatology (Oxford)"},{"key":"8048_CR95","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1086\/498875","volume":"193","author":"LY Chang","year":"2006","unstructured":"Chang LY, Chiang BL, Kao CL et al (2006) Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan. J Infect Dis 193:283\u2013286","journal-title":"J Infect Dis"},{"issue":"1","key":"8048_CR96","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2334-5-21","volume":"5","author":"JL Robinson","year":"2005","unstructured":"Robinson JL, Spady DW, Prasad E, McColl D, Artsob H (2005) Bartonella seropositivity in children with Henoch\u2013Schonlein purpura. BMC Infec Dis 5(1):21","journal-title":"BMC Infec Dis"},{"key":"8048_CR97","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1128\/JVI.80.1.192-200.2006","volume":"80","author":"AL Steed","year":"2006","unstructured":"Steed AL, Barton ES, Tibbetts SA et al (2006) Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol 80:192\u2013200","journal-title":"J Virol"},{"key":"8048_CR98","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1248\/bpb.29.1854","volume":"29","author":"H Shinohara","year":"2006","unstructured":"Shinohara H, Nagi-Miura N, Ishibashi K et al (2006) Beta-mannosyl linkages negatively regulate anaphylaxis and vasculitis in mice, induced by CAWS, fungal PAMPS composed of mannoprotein-beta-glucan complex secreted by Candida albicans. Biol Pharm Bull 29:1854\u20131861","journal-title":"Biol Pharm Bull"},{"issue":"Pt 9","key":"8048_CR99","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/brain\/awl192","volume":"129","author":"U Malipiero","year":"2006","unstructured":"Malipiero U, Koedel U, Pfister HW et al (2006) TGFbeta receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis. Brain 129(Pt 9):2404\u20132415","journal-title":"Brain"},{"key":"8048_CR100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)62952-5","volume":"167","author":"D Huugen","year":"2005","unstructured":"Huugen D, Xiao H, van Esch A et al (2005) Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol 167:47\u201358","journal-title":"Am J Pathol"},{"key":"8048_CR101","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/art.21906","volume":"54","author":"JE Gottenberg","year":"2006","unstructured":"Gottenberg JE, Pallier C, Ittah M et al (2006) Failure to confirm coxsackievirus infection in primary Sjogren's syndrome. Arthritis Rheum 54:2026\u20132028","journal-title":"Arthritis Rheum"},{"key":"8048_CR102","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/1529-0131(199812)41:12<2175::AID-ART12>3.0.CO;2-I","volume":"41","author":"M Fleck","year":"1998","unstructured":"Fleck M, Kern ER, Zhou T, Lang B, Mountz JD (1998) Murine cytomegalovirus induces a Sjogren\u2019s syndrome-like disease in C57Bl\/6-lpr\/lpr mice. Arthritis Rheum 41:2175\u20132184","journal-title":"Arthritis Rheum"},{"key":"8048_CR103","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1521-6616(03)00197-9","volume":"109","author":"S Watanabe","year":"2003","unstructured":"Watanabe S, Suzuki K, Kawauchi Y et al (2003) Kinetic analysis of the development of pancreatic lesions in mice infected with a murine retrovirus. Clin Immunol 109:212\u2013223","journal-title":"Clin Immunol"},{"key":"8048_CR104","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/105072502320288483","volume":"12","author":"D Corapcioglu","year":"2002","unstructured":"Corapcioglu D, Tonyukuk V, Kiyan M et al (2002) Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. Thyroid 12:613\u2013617","journal-title":"Thyroid"},{"key":"8048_CR105","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF01375653","volume":"16","author":"O Maki-Ikola","year":"1997","unstructured":"Maki-Ikola O, Heesemann J, Toivanen A, Granfors K (1997) High frequency of Yersinia antibodies in healthy populations in Finland and Germany. Rheumatol Int 16:227\u2013229","journal-title":"Rheumatol Int"},{"key":"8048_CR106","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2249.2006.03183.x","volume":"146","author":"PS Hansen","year":"2006","unstructured":"Hansen PS, Wenzel BE, Brix TH, Hegedus L (2006) Yersinia enterocolitica infection does not confer an increased risk of thyroid antibodies: evidence from a Danish twin study. Clin Exp Immunol 146:32\u201338","journal-title":"Clin Exp Immunol"},{"key":"8048_CR107","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","volume":"43","author":"JC Mandac","year":"2006","unstructured":"Mandac JC, Chaudhry S, Sherman KE, Tomer Y (2006) The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology (Baltimore) 43:661\u2013672","journal-title":"Hepatology (Baltimore)"},{"key":"8048_CR108","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2310\/6650.2005.00002","volume":"53","author":"R Minelli","year":"2005","unstructured":"Minelli R, Coiro V, Valli MA et al (2005) Graves\u2019 disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection. J Investig Med 53:26\u201330","journal-title":"J Investig Med"},{"key":"8048_CR109","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2249.2004.02641.x","volume":"138","author":"Y Nagayama","year":"2004","unstructured":"Nagayama Y, Saitoh O, McLachlan SM, Rapoport B, Kano H, Kumazawa Y (2004) TSH receptor-adenovirus-induced Graves\u2019 hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1\/Th2 paradigm. Clin Exp Immunol 138:417\u2013422","journal-title":"Clin Exp Immunol"},{"key":"8048_CR110","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1210\/en.2005-1024","volume":"147","author":"O Saitoh","year":"2006","unstructured":"Saitoh O, Nagayama Y (2006) Regulation of Graves\u2019 hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology 147:2417\u20132422","journal-title":"Endocrinology"},{"key":"8048_CR111","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1210\/me.2004-0100","volume":"19","author":"N Harii","year":"2005","unstructured":"Harii N, Lewis CJ, Vasko V et al (2005) Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto\u2019s autoimmune thyroiditis. Mol Endocrinol (Baltimore) 19:1231\u20131250","journal-title":"Mol Endocrinol (Baltimore)"},{"key":"8048_CR112","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.4049\/jimmunol.173.3.2167","volume":"173","author":"Y Nagayama","year":"2004","unstructured":"Nagayama Y, Watanabe K, Niwa M, McLachlan SM, Rapoport B (2004) Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves\u2019 hyperthyroidism. J Immunol 173:2167\u20132173","journal-title":"J Immunol"},{"key":"8048_CR113","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/08916930500485002","volume":"39","author":"E Cunha-Neto","year":"2006","unstructured":"Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM (2006) Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39:41\u201354","journal-title":"Autoimmunity"},{"key":"8048_CR114","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1191\/0961203305lu2192oa","volume":"14","author":"D Fairweather","year":"2005","unstructured":"Fairweather D, Rose NR (2005) Inflammatory heart disease: a role for cytokines. Lupus 14:646\u2013651","journal-title":"Lupus"},{"issue":"6\u20137","key":"8048_CR115","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/00365540500372903","volume":"38","author":"P Kotilainen","year":"2006","unstructured":"Kotilainen P, Lehtopolku M, Hakanen AJ (2006) Myopericarditis in a patient with Campylobacter enteritis: a case report and literature review. Scand J Infec Dis 38(6\u20137):549\u2013552","journal-title":"Scand J Infec Dis"},{"key":"8048_CR116","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4049\/jimmunol.174.1.261","volume":"174","author":"D Fairweather","year":"2005","unstructured":"Fairweather D, Frisancho-Kiss S, Yusung SA et al (2005) IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol 174:261\u2013269","journal-title":"J Immunol"},{"key":"8048_CR117","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1161\/01.RES.0000154263.70223.13","volume":"96","author":"T Omura","year":"2005","unstructured":"Omura T, Yoshiyama M, Hayashi T et al (2005) Core protein of hepatitis C virus induces cardiomyopathy. Circ Res 96:148\u2013150","journal-title":"Circ Res"},{"issue":"3","key":"8048_CR118","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.clim.2006.07.009","volume":"121","author":"MJ Richer","year":"2006","unstructured":"Richer MJ, Fang D, Shanina I, Horwitz MS (2006) Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus-mediated autoimmune myocarditis. Clin Immunol 121(3):339\u2013349","journal-title":"Clin Immunol"},{"key":"8048_CR119","volume-title":"Infection and autoimmunity","author":"M Afanasyeva","year":"2004","unstructured":"Afanasyeva M, Rose NR (2004) Viral infection and heart disease: autoimmune mechanisms. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam"},{"key":"8048_CR120","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/aje\/kwj260","volume":"164","author":"C Green","year":"2006","unstructured":"Green C, Elliott L, Beaudoin C, Bernstein CN (2006) A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 164:615\u2013623 (discussion 24\u201328)","journal-title":"Am J Epidemiol"},{"key":"8048_CR121","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.0083-8703.2006.00368.x","volume":"11","author":"AG Oliveira","year":"2006","unstructured":"Oliveira AG, Rocha GA, Rocha AM et al (2006) Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn\u2019s disease. Helicobacter 11:2\u20139","journal-title":"Helicobacter"},{"key":"8048_CR122","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1083-4389.2004.00223.x","volume":"9","author":"L Pronai","year":"2004","unstructured":"Pronai L, Schandl L, Orosz Z, Magyar P, Tulassay Z (2004) Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease\u2014antibiotic use in the history does not play a significant role. Helicobacter 9:278\u2013283","journal-title":"Helicobacter"},{"key":"8048_CR123","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ejim.2004.11.008","volume":"16","author":"A Saebo","year":"2005","unstructured":"Saebo A, Vik E, Lange OJ, Matuszkiewicz L (2005) Inflammatory bowel disease associated with Yersinia enterocolitica O:3 infection. Eur J Intern Med 16:176\u2013182","journal-title":"Eur J Intern Med"},{"key":"8048_CR124","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/00054725-200502000-00004","volume":"11","author":"C Romero","year":"2005","unstructured":"Romero C, Hamdi A, Valentine JF, Naser SA (2005) Evaluation of surgical tissue from patients with Crohn\u2019s disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction. Inflamm Bowel Dis 11:116\u2013125","journal-title":"Inflamm Bowel Dis"},{"key":"8048_CR125","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/j.gastro.2006.04.021","volume":"131","author":"D Polymeros","year":"2006","unstructured":"Polymeros D, Bogdanos DP, Day R, Arioli D, Vergani D, Forbes A (2006) Does cross-reactivity between Mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn\u2019s disease? Gastroenterology 131:85\u201396","journal-title":"Gastroenterology"},{"key":"8048_CR126","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/B978-044451271-0.50051-X","volume-title":"Infection and Autoimmunity","author":"JV Weinstock","year":"2004","unstructured":"Weinstock JV (2004) Inflammatory bowel disease. In: Shoenfeld Y, Rose NR (eds) Infection and Autoimmunity. 1st edn. Elsevier, Amsterdam, pp 649\u2013673","edition":"1"},{"key":"8048_CR127","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3748\/wjg.v12.i21.3306","volume":"12","author":"P Gionchetti","year":"2006","unstructured":"Gionchetti P, Rizzello F, Lammers KM et al (2006) Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 12:3306\u20133313","journal-title":"World J Gastroenterol"},{"key":"8048_CR128","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10620-005-2663-0","volume":"50","author":"BC Sydora","year":"2005","unstructured":"Sydora BC, Tavernini MM, Doyle JS, Fedorak RN (2005) Association with selected bacteria does not cause enterocolitis in IL-10 gene-deficient mice despite a systemic immune response. Dig Dis Sci 50:905\u2013913","journal-title":"Dig Dis Sci"},{"key":"8048_CR129","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/gut.53.1.99","volume":"53","author":"TG Moreels","year":"2004","unstructured":"Moreels TG, Nieuwendijk RJ, De Man JG et al (2004) Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut 53:99\u2013107","journal-title":"Gut"},{"key":"8048_CR130","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.4049\/jimmunol.174.11.7368","volume":"174","author":"MM Hunter","year":"2005","unstructured":"Hunter MM, Wang A, Hirota CL, McKay DM (2005) Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J Immunol 174:7368\u20137375","journal-title":"J Immunol"},{"key":"8048_CR131","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1053\/j.gastro.2005.01.005","volume":"128","author":"RW Summers","year":"2005","unstructured":"Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV (2005) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128:825\u2013832","journal-title":"Gastroenterology"},{"key":"8048_CR132","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/ajh.20408","volume":"80","author":"M Szyper-Kravitz","year":"2005","unstructured":"Szyper-Kravitz M, Shoenfeld Y (2005) Thrombocytopenic conditions\u2014autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT and APS. Am J Hematol 80:232\u2013242","journal-title":"Am J Hematol"},{"key":"8048_CR133","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/j.1572-0241.2005.41641.x","volume":"100","author":"T Suzuki","year":"2005","unstructured":"Suzuki T, Matsushima M, Masui A et al (2005) Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura\u2014a randomized controlled trial. Am J Gastroenterol 100:1265\u20131270","journal-title":"Am J Gastroenterol"},{"key":"8048_CR134","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.amjmed.2004.09.014","volume":"118","author":"R Stasi","year":"2005","unstructured":"Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D (2005) Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 118:414\u2013419","journal-title":"Am J Med"},{"key":"8048_CR135","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.autrev.2004.11.010","volume":"4","author":"A Musaji","year":"2005","unstructured":"Musaji A, Meite M, Detalle L et al (2005) Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia. Autoimmunity Rev 4:247\u2013252","journal-title":"Autoimmunity Rev"},{"key":"8048_CR136","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1182\/blood-2005-01-0243","volume":"106","author":"Z Li","year":"2005","unstructured":"Li Z, Nardi MA, Karpatkin S (2005) Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood 106:572\u2013576","journal-title":"Blood"},{"key":"8048_CR137","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/B978-044451271-0.50046-6","volume-title":"Infection and autoimmunity","author":"NM van Sorge","year":"2004","unstructured":"van Sorge NM, van den Berg LH, Jansen MD, van de Winkel JGJ, van der Pol WL (2004) Infection and Guillain-Barr\u00e9 syndrome. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 591\u2013612"},{"key":"8048_CR138","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1086\/504294","volume":"194","author":"CC Tam","year":"2006","unstructured":"Tam CC, Rodrigues LC, Petersen I, Islam A, Hayward A, O'Brien SJ (2006) Incidence of Guillain\u2013Barre syndrome among patients with Campylobacter infection: a general practice research database study. J Infect Dis 194:95\u201397","journal-title":"J Infect Dis"},{"key":"8048_CR139","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1468-1331.2004.00977.x","volume":"12","author":"J Kountouras","year":"2005","unstructured":"Kountouras J, Deretzi G, Zavos C et al (2005) Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 12:139\u2013143","journal-title":"Eur J Neurol"},{"key":"8048_CR140","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.femsim.2005.03.001","volume":"45","author":"K Watanabe","year":"2005","unstructured":"Watanabe K, Kim S, Nishiguchi M, Suzuki H, Watarai M (2005) Brucella melitensis infection associated with Guillain\u2013Barre syndrome through molecular mimicry of host structures. FEMS Iimmunol Med Microbiol 45:121\u2013127","journal-title":"FEMS Iimmunol Med Microbiol"},{"key":"8048_CR141","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1172\/JCI200415707","volume":"114","author":"PC Godschalk","year":"2004","unstructured":"Godschalk PC, Heikema AP, Gilbert M et al (2004) The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain\u2013Barre syndrome. J Clin Invest 114:1659\u20131665","journal-title":"J Clin Invest"},{"key":"8048_CR142","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S1521-6616(03)00046-9","volume":"107","author":"MR Geier","year":"2003","unstructured":"Geier MR, Geier DA, Zahalsky AC (2003) Influenza vaccination and Guillain\u2013Barre syndrome. Clin Immunol 107:116\u2013121","journal-title":"Clin Immunol"},{"key":"8048_CR143","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaut.2005.01.007","volume":"24","author":"KC Fae","year":"2005","unstructured":"Fae KC, Oshiro SE, Toubert A, Charron D, Kalil J, Guilherme L (2005) How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J Autoimmun 24:101\u2013109","journal-title":"J Autoimmun"},{"key":"8048_CR144","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.molimm.2003.11.007","volume":"40","author":"K Fae","year":"2004","unstructured":"Fae K, Kalil J, Toubert A, Guilherme L (2004) Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern. Mol Immunol 40:1129\u20131135","journal-title":"Mol Immunol"},{"key":"8048_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S146239940501015X","volume":"7","author":"L Guilherme","year":"2005","unstructured":"Guilherme L, Fae K, Oshiro SE, Kalil J (2005) Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev Mol Med 7:1\u201315","journal-title":"Expert Rev Mol Med"},{"key":"8048_CR146","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1086\/504266","volume":"193","author":"C Olive","year":"2006","unstructured":"Olive C, Ho MF, Dyer J et al (2006) Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis 193:1666\u20131676","journal-title":"J Infect Dis"},{"key":"8048_CR147","first-page":"159","volume":"99","author":"G Giovannoni","year":"2006","unstructured":"Giovannoni G (2006) PANDAS: overview of the hypothesis. Adv Neurol 99:159\u2013165","journal-title":"Adv Neurol"},{"key":"8048_CR148","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","volume":"354","author":"SJ Perlmutter","year":"1999","unstructured":"Perlmutter SJ, Leitman SF, Garvey MA et al (1999) Therapeutic plasma exchange and intravenous immunoglobulin for obsessive\u2013compulsive disorder and tic disorders in childhood. Lancet 354:1153\u20131158","journal-title":"Lancet"},{"key":"8048_CR149","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/mds.20052","volume":"19","author":"HS Singer","year":"2004","unstructured":"Singer HS, Loiselle CR, Lee O, Minzer K, Swedo S, Grus FH (2004) Anti-basal ganglia antibodies in PANDAS. Mov Disord 19:406\u2013415","journal-title":"Mov Disord"},{"key":"8048_CR150","volume-title":"Evolution in four dimensions","author":"E Jablonka","year":"2005","unstructured":"Jablonka E, Lamb M (2005) Evolution in four dimensions, 1st edn. MIT Press, Boston","edition":"1"},{"key":"8048_CR151","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1126\/science.288.5464.287","volume":"288","author":"J Lederberg","year":"2000","unstructured":"Lederberg J (2000) Infectious history. Science 288:287\u2013293","journal-title":"Science"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8048-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-007-8048-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8048-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8048-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:54:39Z","timestamp":1744163679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-007-8048-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,30]]},"references-count":151,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["8048"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-8048-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,30]]},"assertion":[{"value":"30 January 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}